Peptides for PTSD & Trauma Recovery: Evidence vs Hype (2026)
An evidence-graded look at the three peptides marketed for PTSD and trauma — oxytocin, Selank and Semax — separating the mixed human oxytocin RCTs from anxiety-only and preclinical claims.
Anxiolytic Peptides
Anxiolytic Peptides is a recurring topic in our peptide coverage. This hub collects every article tagged Anxiolytic Peptides, newest first, each evidence-graded and tied to real, verifiable sources.
Best Peptides for Anxiety & Stress: Clinical Evidence (2026)
A clinical, evidence-graded look at the four peptides marketed for anxiety and stress — Selank, N-Acetyl Selank Amidate, Semax and DSIP — separating the single human anxiety trial from preclinical and marketing claims.
Selank: Evidence, Mechanism, Dosing & Legal Status
A clinical monograph on Selank (TP-7) — the Russian tuftsin-analog anxiolytic peptide. Small human anxiety trials, a mostly preclinical mechanism, and an unsettled 2026 US legal status.
N-Acetyl Selank Amidate: Evidence, Mechanism & Legal Status
A clinical monograph on N-Acetyl Selank Amidate — a twice-stabilized analog of the Russian anxiolytic peptide Selank. No dedicated human or animal study exists; every claim is extrapolated, placing the analog itself at evidence grade D.
Frequently asked
What is Anxiolytic Peptides?
Anxiolytic Peptides is a topic our editors cover across the site. This hub aggregates the related, evidence-graded guidance.
How often is the Anxiolytic Peptides hub updated?
This hub updates automatically whenever a new article is tagged Anxiolytic Peptides, so the latest coverage appears first.
Are Anxiolytic Peptides claims sourced?
Yes. Every article here grades its efficacy claims A-D and cites real, verifiable studies, regulatory documents or trial registries.